(Q37900639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

review article

1 reference

title

DiaPep277 peptide therapy in the context of other immune intervention trials in type 1 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Paolo Pozzilli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Elvira Fioriti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Silvia Manfrini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Eugenio D'Amico

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

13 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1233-1240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

Autoimmune destruction of pancreatic beta cells.

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Autoimmunity and the pathogenesis of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Targeting type 1 diabetes before and at the clinical onset of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Immunotherapy for the prevention and treatment of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Use of anti-CD3 monoclonal antibody to induce immune regulation in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Prediction of type 1 diabetes in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

GAD treatment and insulin secretion in recent-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Emerging treatments for the prevention of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Teplizumab therapy for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Regulatory T cells and immune computation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Immunomodulation with heat shock protein DiaPep277 to preserve beta cell function in type 1 diabetes - an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

An update on preventive and regenerative therapies in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.599319

10.1517/14712598.2011.599319

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751937%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference